MET GENE ALTERATIONS

Clinical trials for MET GENE ALTERATIONS explained in plain language.

Never miss a new study

Get alerted when new MET GENE ALTERATIONS trials appear

Sign up with your email to follow new studies for MET GENE ALTERATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough cancers: first human test of targeted drug begins

Disease control Ongoing

This is an early-stage study to test a new oral drug called TPX-0022 (elzovantinib) in adults with advanced or spreading cancers that have specific changes in a gene called MET. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at w…

Matched conditions: MET GENE ALTERATIONS

Phase: PHASE1 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

MET GENE ALTERATIONS

Get alerted when new MET GENE ALTERATIONS trials appear

New hope for tough cancers: first human test of targeted drug begins